“It is declared the policy of this act to make investigation and arrest of adults [18+] for non-commercial planting, cultivating, purchasing, transporting, distributing, possessing or engaging in practices with entheogenic plants and fungi among the lowest law enforcement priorities for the District of Columbia…” this is a notable accomplishment for advocates, as Congress has previously…
Compass will now have three months to respond to each filing. Then, the Patent Trial and Appeal Board, a collection of administrative judges… will make a decision as to whether the petitioner demonstrates that at least one of the challenged claims is “more likely than not” unpatentable—and whether the case should proceed to a trial.…
…struggling with mental health conditions [&] have received exemptions to the Controlled Drugs and Substances Act from the federal Minister of Health Jean-Yves Duclos. …mandamus application to compel the health minister to make a decision regarding… patient’s Section 56 exemptions… Health Canada fought that application “tooth and nail”… 19 healthcare professionals to receive an exemption……
[Canadian] Municipalities cannot unilaterally decriminalize drug use as it’s the sole responsibility of the federal government, but [the 12/6/2021] vote authorizes de Villa to seek an exemption for the City of Toronto from Health Canada. Dr. Leslie Buckley, chief of the addictions division at Toronto’s Centre for Addiction and Mental Health, said “Criminalization of substances has not been…
D.C. voters legalized the possession, home cultivation and gifting of adult-use cannabis in 2014, a congressional rider has blocked the District from using its tax dollars to implement a regulated system of sales. They heard numerous recommendations on the legalization proposal, ranging from enhancing social equity provisions to ensuring that medical cannabis patients continue to…
Consultant psychiatrist Eli Kotler launched legal action after the Victorian Department of Health knocked back an application to treat the woman… with the drug more commonly known as ecstasy. Kylie Evans, the barrister representing Victoria’s Health Department, told the court that the outcome of the case would be significant… the move will be opposed by…
As psychedelic firms skyrocket in market cap, quick cashouts are extracting billions of dollars in value – with no benefit to society… I’ve questioned the incentives of those investing in the psychedelic space… financial motivations to make a quick exit. These exits are ultimately extractive, and raise the cost of treatments, rendering them inaccessible to…
Psychedelic psilocybin was approved by voters last fall for limited, therapeutic use, but “remains a Schedule 1 controlled substance,” the sergeant noted… during the search of the home, detectives found an active psilocybin grow chamber in the children’s play area and toy storage area, the sergeant said. The man was cited and released at the…
They helped create the disease, and now they want to hoard the cure. This was the plug for Prozac when it first came on the market in 1988… no matter: a new therapeutic savior has arrived in the form of psychedelics. If you think it’s a little strange that Big Tech – currently best known…
The fact that someone who tried psychedelics for the first time in 2014 now talks openly about restricting access to them might be unsettling to many in the psychedelic community. But some investors are already adopting a gatekeeping approach to these ancient medicines. For example, German billionaire Christian Angermayer, founder of biotech company Atai Life…
